Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

ForteBio Acquired by Pall Corporation

publication date: Dec 21, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
ForteBio, a venture backed company that makes instruments for biotech drug development, was acquired by Pall Corporation for an undisclosed sum. ForteBio produces systems that enable real-time analysis of biomolecular interactions. Based in Menlo Park, Forte has a wholly-owned manufacturing subsidiary in Shanghai's Zhangjiang Hi-Tech Park. More details....

Stock Symbol: (NYSE: PLL)     Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...